Widmer N - Search Results

1

Example-based support vector machine for drug concentration analysis.

You W, Widmer N, De Micheli G. You W, et al. Among authors: widmer n. Annu Int Conf IEEE Eng Med Biol Soc. 2011;2011:153-7. doi: 10.1109/IEMBS.2011.6089917. Annu Int Conf IEEE Eng Med Biol Soc. 2011. PMID: 22254273

2

Monitoring drug therapy.

Buclin T, Gotta V, Fuchs A, Widmer N, Aronson J. Buclin T, et al. Among authors: widmer n. Br J Clin Pharmacol. 2012 Jun;73(6):917-23. doi: 10.1111/j.1365-2125.2012.04237.x. Br J Clin Pharmacol. 2012. PMID: 22360377 Free PMC article.

3

Benchmarking therapeutic drug monitoring software: a review of available computer tools.

Fuchs A, Csajka C, Thoma Y, Buclin T, Widmer N. Fuchs A, et al. Among authors: widmer n. Clin Pharmacokinet. 2013 Jan;52(1):9-22. doi: 10.1007/s40262-012-0020-y. Clin Pharmacokinet. 2013. PMID: 23196713 Review.

4

Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates.

Fuchs A, Guidi M, Giannoni E, Werner D, Buclin T, Widmer N, Csajka C. Fuchs A, et al. Among authors: widmer n. Br J Clin Pharmacol. 2014 Nov;78(5):1090-101. doi: 10.1111/bcp.12444. Br J Clin Pharmacol. 2014. PMID: 24938850 Free PMC article.

5

Therapeutic Drug Monitoring of Targeted Anticancer Protein Kinase Inhibitors in Routine Clinical Use: A Critical Review.

Cardoso E, Guidi M, Blanchet B, Schneider MP, Decosterd LA, Buclin T, Csajka C, Widmer N. Cardoso E, et al. Among authors: widmer n. Ther Drug Monit. 2020 Feb;42(1):33-44. doi: 10.1097/FTD.0000000000000699. Ther Drug Monit. 2020. PMID: 31479043

6

Therapeutic drug monitoring in cancer--are we missing a trick?

Bardin C, Veal G, Paci A, Chatelut E, Astier A, Levêque D, Widmer N, Beijnen J. Bardin C, et al. Among authors: widmer n. Eur J Cancer. 2014 Aug;50(12):2005-9. doi: 10.1016/j.ejca.2014.04.013. Epub 2014 May 27. Eur J Cancer. 2014. PMID: 24878063

7

Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial.

Gotta V, Widmer N, Decosterd LA, Chalandon Y, Heim D, Gregor M, Benz R, Leoncini-Franscini L, Baerlocher GM, Duchosal MA, Csajka C, Buclin T. Gotta V, et al. Among authors: widmer n. Cancer Chemother Pharmacol. 2014 Dec;74(6):1307-19. doi: 10.1007/s00280-014-2599-1. Epub 2014 Oct 9. Cancer Chemother Pharmacol. 2014. PMID: 25297989 Free article. Clinical Trial.

8

Therapeutic drug monitoring of targeted anticancer therapy.

Decosterd LA, Widmer N, Zaman K, Cardoso E, Buclin T, Csajka C. Decosterd LA, et al. Among authors: widmer n. Biomark Med. 2015;9(9):887-93. doi: 10.2217/bmm.15.78. Epub 2015 Sep 3. Biomark Med. 2015. PMID: 26333311 Review.

9

Therapeutic drug monitoring of imatinib: Bayesian and alternative methods to predict trough levels.

Gotta V, Widmer N, Montemurro M, Leyvraz S, Haouala A, Decosterd LA, Csajka C, Buclin T. Gotta V, et al. Among authors: widmer n. Clin Pharmacokinet. 2012 Mar 1;51(3):187-201. doi: 10.2165/11596990-000000000-00000. Clin Pharmacokinet. 2012. PMID: 22339450

10

Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics.

Paci A, Veal G, Bardin C, Levêque D, Widmer N, Beijnen J, Astier A, Chatelut E. Paci A, et al. Among authors: widmer n. Eur J Cancer. 2014 Aug;50(12):2010-9. doi: 10.1016/j.ejca.2014.04.014. Epub 2014 Jun 2. Eur J Cancer. 2014. PMID: 24889915 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page